Press release
Chemotherapy Induced Nausea and Vomiting Pipeline Appears Robust With 4+ Key Pharma Companies Actively Working in the Therapeutics Segment | DelveInsight
DelveInsight's, "Chemotherapy Induced Nausea and Vomiting Pipeline Insight 2025" report provides comprehensive insights about 4+ companies and 6+ pipeline drugs in Chemotherapy Induced Nausea and Vomiting pipeline landscape. It covers the Chemotherapy Induced Nausea and Vomiting pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.Discover the latest drugs and treatment options in the Chemotherapy Induced Nausea and Vomiting Pipeline. Dive into DelveInsight's comprehensive report today! @ Chemotherapy Induced Nausea and Vomiting Pipeline Outlook [https://www.delveinsight.com/sample-request/chemotherapy-induced-nausea-and-vomiting-pipeline-insight?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=ypr]
Key Takeaways from the Chemotherapy Induced Nausea and Vomiting Pipeline Report
* In April 2025, Arbeitsgemeinschaft medikamentoese Tumortherapie conducted a phase III trial is to investigate the efficacy and safety of dronabinol (orally administered tetrahydrocannabinol (THC)) as adjuvant therapy to first-line standard chemotherapy in patients with metastatic pancreatic cancer for improvement of chemotherapy- and tumor-related symptoms applicated by individual titration up to the maximum tolerated dose.
* DelveInsight's Chemotherapy Induced Nausea and Vomiting Pipeline report depicts a robust space with 4+ active players working to develop 6+ pipeline therapies for Chemotherapy Induced Nausea and Vomiting treatment.
* The leading Chemotherapy Induced Nausea and Vomiting Companies such as RedHill Biopharma, Acacia Pharma, Camurus AB, Fujian Shengdi Pharmaceutical Co., Ltd and others.
* Promising Chemotherapy Induced Nausea and Vomiting Pipeline Therapies such as GW679769, Dexamethasone, Ondansetron Hydrochloride, Akynzeo, Fosaprepitant Dimeglumine, Intranasal granisetron, Rolapitant, Granisetron , and others.
Stay ahead with the most recent pipeline outlook for Chemotherapy Induced Nausea and Vomiting. Get insights into clinical trials, emerging therapies, and leading companies with Chemotherapy Induced Nausea and Vomiting @ Chemotherapy Induced Nausea and Vomiting Treatment Drugs [https://www.delveinsight.com/sample-request/chemotherapy-induced-nausea-and-vomiting-pipeline-insight?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=ypr]
Chemotherapy Induced Nausea and Vomiting Emerging Drugs Profile
* RHB-102: RedHill Biopharma
RHB-102 is a patent-protected, proprietary, once-daily, bimodal extended-release, oral tablet formulation of the antiemetic drug ondansetron, a 5-HT3 antagonist, targeting potential indications including oncology support, acute gastroenteritis and gastritis, and IBS-D at two dose strengths, 12mg and 24mg. RedHill Biopharma entered into an exclusive worldwide development and commercialization licensing agreement, excluding North America, with Hyloris Pharmaceuticals for RHB-102 for gastroenteritis & gastritis, IBS-D and oncology support. Currently, the drug is in Phase III stage of its development for the treatment of Chemotherapy Induced Nausea and Vomiting.
* APD403: Acacia Pharma
APD403 is based on the selective dopamine antagonist amisulpride, the same active ingredient as in Barhemsys Registered . It is being developed as an intravenous injection for cancer patients to be administered immediately before they receive chemotherapy to prevent acute CINV, and as an oral tablet to prevent delayed CINV. APD403 has successfully completed one proof-of-concept and one Phase II dose-ranging study demonstrating it is well tolerated and effective at preventing acute and delayed CINV. Currently, the drug is in Phase II stage of its development for the treatment of Chemotherapy Induced Nausea and Vomiting.
The Chemotherapy Induced Nausea and Vomiting Pipeline Report Provides Insights into-
* The report provides detailed insights about companies that are developing therapies for the treatment of Chemotherapy Induced Nausea and Vomiting with aggregate therapies developed by each company for the same.
* It accesses the Different therapeutic candidates segmented into early-stage, mid-stage, and late-stage of development for Chemotherapy Induced Nausea and Vomiting Treatment.
* Chemotherapy Induced Nausea and Vomiting Companies are involved in targeted therapeutics development with respective active and inactive (dormant or discontinued) projects.
* Chemotherapy Induced Nausea and Vomiting Drugs under development based on the stage of development, route of administration, target receptor, monotherapy or combination therapy, a different mechanism of action, and molecular type.
* Detailed analysis of collaborations (company-company collaborations and company-academia collaborations), licensing agreement and financing details for future advancement of the Chemotherapy Induced Nausea and Vomiting market
Explore groundbreaking therapies and clinical trials in the Chemotherapy Induced Nausea and Vomiting Pipeline. Access DelveInsight's detailed report now! @ New Chemotherapy Induced Nausea and Vomiting Drugs [https://www.delveinsight.com/sample-request/chemotherapy-induced-nausea-and-vomiting-pipeline-insight?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=ypr]
Chemotherapy Induced Nausea and Vomiting Companies
RedHill Biopharma, Acacia Pharma, Camurus AB, Fujian Shengdi Pharmaceutical Co., Ltd and others.
Chemotherapy Induced Nausea and Vomiting pipeline report provides the therapeutic assessment of the pipeline drugs by the Route of Administration. Products have been categorized under various ROAs such as
* Oral
* Intravenous
* Subcutaneous
* Parenteral
* Topical
Chemotherapy Induced Nausea and Vomiting Products have been categorized under various Molecule types such as
* Recombinant fusion proteins
* Small molecule
* Monoclonal antibody
* Peptide
* Polymer
* Gene therapy
Unveil the future of Chemotherapy Induced Nausea and Vomiting Treatment. Learn about new drugs, Chemotherapy Induced Nausea and Vomiting Pipeline developments, and key companies with DelveInsight's expert analysis @ Chemotherapy Induced Nausea and Vomiting Market Drivers and Barriers [https://www.delveinsight.com/sample-request/chemotherapy-induced-nausea-and-vomiting-pipeline-insight?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=ypr]
Scope of the Chemotherapy Induced Nausea and Vomiting Pipeline Report
* Coverage- Global
* Chemotherapy Induced Nausea and Vomiting Companies- RedHill Biopharma, Acacia Pharma, Camurus AB, Fujian Shengdi Pharmaceutical Co., Ltd and others.
* Chemotherapy Induced Nausea and Vomiting Pipeline Therapies- GW679769, Dexamethasone, Ondansetron Hydrochloride, Akynzeo, Fosaprepitant Dimeglumine, Intranasal granisetron, Rolapitant, Granisetron , and others.
* Chemotherapy Induced Nausea and Vomiting Therapeutic Assessment by Product Type: Mono, Combination, Mono/Combination
* Chemotherapy Induced Nausea and Vomiting Therapeutic Assessment by Clinical Stages: Discovery, Pre-clinical, Phase I, Phase II, Phase III
Get the latest on Chemotherapy Induced Nausea and Vomiting Pipeline Therapies and clinical trials. Download DelveInsight's in-depth pipeline report today! @ Chemotherapy Induced Nausea and Vomiting Companies, Key Products and Unmet Needs [https://www.delveinsight.com/sample-request/chemotherapy-induced-nausea-and-vomiting-pipeline-insight?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=ypr]
Table of Contents
* Introduction
* Executive Summary
* Chemotherapy Induced Nausea and Vomiting: Overview
* Pipeline Therapeutics
* Therapeutic Assessment
* Chemotherapy Induced Nausea and Vomiting- DelveInsight's Analytical Perspective
* Late Stage Products (Phase III)
* RHB-102: RedHill Biopharma
* Drug profiles in the detailed report.....
* Mid Stage Products (Phase II)
* APD403: Acacia Pharma
* Drug profiles in the detailed report.....
* Early Stage Products (Phase I)
* Drug Name: Company Name
* Drug profiles in the detailed report.....
* Preclinical and Discovery Stage Products
* Drug Name: Company Name
* Drug profiles in the detailed report.....
* Inactive Products
* Chemotherapy Induced Nausea and Vomiting Key Companies
* Chemotherapy Induced Nausea and Vomiting Key Products
* Chemotherapy Induced Nausea and Vomiting- Unmet Needs
* Chemotherapy Induced Nausea and Vomiting- Market Drivers and Barriers
* Chemotherapy Induced Nausea and Vomiting- Future Perspectives and Conclusion
* Chemotherapy Induced Nausea and Vomiting Analyst Views
* Chemotherapy Induced Nausea and Vomiting Key Companies
* Appendix
About Us
DelveInsight is a leading healthcare-focused market research and consulting firm that provides clients with high-quality market intelligence and analysis to support informed business decisions. With a team of experienced industry experts and a deep understanding of the life sciences and healthcare sectors, we offer customized research solutions and insights to clients across the globe. Connect with us to get high-quality, accurate, and real-time intelligence to stay ahead of the growth curve.
Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Yash Bhardwaj
Email:Send Email [https://www.abnewswire.com/email_contact_us.php?pr=chemotherapy-induced-nausea-and-vomiting-pipeline-appears-robust-with-4-key-pharma-companies-actively-working-in-the-therapeutics-segment-delveinsight]
Phone: 09650213330
Address:304 S. Jones Blvd #2432
City: Las Vegas
State: NV
Country: United States
Website: https://www.delveinsight.com/report-store/chemotherapy-induced-nausea-and-vomiting-pipeline-insight
Legal Disclaimer: Information contained on this page is provided by an independent third-party content provider. ABNewswire makes no warranties or responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you are affiliated with this article or have any complaints or copyright issues related to this article and would like it to be removed, please contact retract@swscontact.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Chemotherapy Induced Nausea and Vomiting Pipeline Appears Robust With 4+ Key Pharma Companies Actively Working in the Therapeutics Segment | DelveInsight here
News-ID: 4093261 • Views: …
More Releases from ABNewswire

How Bedrock Restoration of Edina Fixes Basement Water Damage for Good
When water seeps into your basement, time is not on your side. Delays in cleanup only make the situation worse and more expensive to fix.
Dealing with basement water damage [https://bedrockrestoration.com/water-damage-restoration-edina-mn/#:~:text=BASEMENT%20WATER%20DAMAGE] is every Edina homeowner's nightmare. Whether it's a sudden flood or hidden leaks over time, moisture in your lower level can quickly lead to structural problems, mold growth, and ruined belongings. When your basement is under threat, it's crucial to…

PF&A Design Named Top Building Architect for Innovative Spaces
From hospitals and community centers to commercial developments and custom residential projects, PF&A Design has built a strong reputation as a local building architect dedicated to enhancing the Norfolk skyline.
When it comes to transforming ideas into award-winning structures, the right building architect [https://www.pfa-architect.com/#:~:text=Top%20healthcare-,architects,-creating%20modern%20facilities] can make all the difference. Many businesses and homeowners looking for a building architect near me have discovered that the true leaders in the field are the…

Dee Agarwal on Recognizing Industries That Are Ripe for Disruption
Dee Agarwal explores how to spot industries ripe for disruption by identifying inefficiencies, outdated assumptions, and cultural lag, urging innovators to look beyond technology and listen closely to what consumers and systems quietly reveal.
ATLANTA, GA - July 4th, 2025 - In the dynamic landscape of modern commerce, innovation is not a mere advantage; it is an existential necessity. Yet while some sectors evolve continuously, others linger in outdated paradigms, creating…

Avenue towards Advanced Dental Implants in Vasai - Rajeshwari Dental Clinic
Based in Palghar, Rajeshwari Dental Clinic is making substantial inroads to become a preferred centre for patients seeking a trusted dental clinic in Vasai, primarily specialising in dental implants in Vasai and All-on-Four dental implants in Vasai. The benchmark set in place for quality treatment in the region is the transparent costs, comprehensive services, and expert leadership.
An ever-growing healthcare corridor from Palghar to Vasai, the Rajeshwari Dental Clinic, has become…
More Releases for Chemotherapy
Chemotherapy Devices Market 2022 Will Boom With Advanced Chemotherapy Technologi …
New Research Study ""Chemotherapy Devices Market 2022 analysis by Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges and Investment Opportunities), Size, Share and Outlook"" has been added to Coherent Market insight
The most recent Global Chemotherapy Devices Market report includes a high-level overview of the industry as well as in-depth analysis of key areas. The overview presented highlights the definition of products and services, as well as their associated applications, at the…
Cancer, chemotherapy and its treatment
Chemotherapy is one of the most commonly used cancer therapies. It employs the use of certain medications to destroy cancer cells or prevent them from spreading to other parts of the body. Chemotherapy may be prescribed alone or in combination with surgery or radiation therapy. Along with chemotherapy, you may also take newer types of cancer-fighting medications.
Chemotherapy can be taken as pills or as injections. You may visit a clinic…
Chemotherapy Devices Market Generated Opportunities, Future Scope 2021-2028 | Ad …
The Global Chemotherapy Devices Market, accounted for US$ 10.9 billion in 2017, and is expected to witness a 7.7% CAGR over the forecast period (2018 - 2026).
Technological advancements within cancer treatments including chemotherapy along with rising cancer care investments are decreasing the number of deaths caused by cancer worldwide. As per the 2016 study by Cancer Journal for Clinicians, the amount of cancer survivors grows continuously in the U.S.,…
Chemotherapy induced Nausea and Vomiting (CINV) TreatmentS Market Driven by Risi …
According to WHO cancer is one of the most leading causes for death with around 8 million deaths and 14 million new patients in 2012. Chemotherapy, which is received by approximately four million cancer patients each year, is among the most commonly used treatment to fight cancer. However, this mode of treatment has many side effects, an estimate of around 70% - 80% of the patients receiving chemotherapy treatment experience…
Nano Chemotherapy Market Nano Chemotherapy Clinical Pipeline Report 2022
For Report Sample Contact: neeraj@kuickresearch.com or +91-11-47067990
Report Table of Contents
Nano Chemotherapeutics Mediations andndash; Solicitation to Nanomedicine
1.1 Overview
1.2 Nano Chemotherapeutics with Pharmaceutical Potential
Significance of Nano Chemotherapeutics to overcome the Chemotherapy Limitations
2.1 Limitations of Conventional Chemotherapy
2.2 Nanotechnology in Cancer Targeting
2.2.1 Active Targeting
2.2.2 Passive Targeting
2.2.3 pH Dependent Drug Delivery Through Nanoparticles
Role…
Nano Chemotherapy Is Emerging As An Important Anti-Cancer Modality By Supplement …
“Global Nano Chemotherapy Market and Clinical Trials Outlook 2022” report highlights the current development in the in the field of nano chemotherapy. Report gives comprehensive insight on various clinical and non-clinical parameters associated with the expansion of global nano chemotherapeutics market. The clinical and pricing insight on chemotherapeutics nanoformulations of approved drugs helps to understand the current market scenario of the nano chemotherapeutics.
For Report Sample Contact: neeraj@kuickresearch.com or +91-11-47067990
Download Report:…